Predictors of each quality of life dimension in Crohn’s disease patients initiating an anti-TNF treatment: differentiated effects of patient-, disease-, and treatment-related characteristics

References

• van der Have M, van der Aalst KS, Kaptein AA, et al. Determinants of health-related quality of life in Crohn's disease: a systematic review and meta-analysis. J Crohns Colitis. 2014;8(2):93–106.
   PubMed Web of Science ®Google Scholar
• Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19 Suppl A (Suppl A):5A–36A.
   PubMedGoogle Scholar
• Canavan C, Abrams KR, Hawthorne B, et al. Long-term prognosis in Crohn’s disease: factors that affect quality of life. Aliment Pharmacol Ther. 2006;23(3):377–385.
   PubMed Web of Science ®Google Scholar
• Niv G, Bar Josef S, Ben Bassat O, et al. Quality of life and uncertainty in Crohn's disease. Qual Life Res. 2017;26(6):1609–1616.
   PubMed Web of Science ®Google Scholar
• Chrobak-Bień J, Gawor A, Paplaczyk M, et al. Analysis of factors affecting the quality of life of those suffering from Crohn's disease. Pol Przegl Chir. 2017;89(4):16–22.
   PubMedGoogle Scholar
• Blondel-Kucharski F, Chircop C, Marquis P, et al. Health-related quality of life in Crohn's disease: a prospective longitudinal study in 231 patients. Am J Gastroenterol. 2001;96(10):2915–2920.
   PubMed Web of Science ®Google Scholar
• Blanco BL, Moreno-Jiménez B, Múgica JMD, et al. Relationship between socio-demographic and clinical variables, and health-related quality of life in patients with inflammatory bowel disease. Rev Esp Enferm Dig. 2005;97:12.
   Google Scholar
• Ng SC, Plamondon S, Gupta A, et al. Prospective assessment of the effect on quality of life of anti-tumour necrosis factor therapy for perineal Crohn’s fistulas. Aliment Pharmacol Ther. 2009;30(7):757–766.
   PubMed Web of Science ®Google Scholar
• Sherman M, Tsynman DN, Kim A, et al. Sustained improvement in health-related quality of life measures in patients with inflammatory bowel disease receiving prolonged anti-tumor necrosis factor therapy. J Dig Dis. 2014;15(4):174–179.
   PubMed Web of Science ®Google Scholar
• Mercieca-Bebber R, King MT, Calvert MJ, et al. The importance of patient-reported outcomes in clinical trials and strategies for future optimization. Patient Relat Outcome Meas. 2018;9:353–367.
   PubMed Web of Science ®Google Scholar
• Williet N, Sandborn WJ, Peyrin–Biroulet L. Patient-Reported outcomes as primary end points in clinical trials of inflammatory bowel disease. Clin Gastroenterol Hepatol. 2014;12(8):1246–1256.e6.
   PubMed Web of Science ®Google Scholar
• Peyrin-Biroulet L, Sandborn W, Sands BE, et al. Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-Target. Am J Gastroenterol. 2015;110(9):1324–1338.
   PubMed Web of Science ®Google Scholar
• Wolfe BJ, Sirois FM. Beyond standard quality of life measures: the subjective experiences of living with inflammatory bowel disease. Qual Life Res. 2008;17(6):877–886.
   PubMed Web of Science ®Google Scholar
• van Langenberg DR, Gibson PR. Factors associated with physical and cognitive fatigue in patients with Crohn’s disease: a cross-sectional and longitudinal study. Inflamm Bowel Dis. 2014;20(1):115–125.
   PubMed Web of Science ®Google Scholar
• Iglesias-Rey M, Barreiro-de Acosta M, Caamaño-Isorna F, et al. Psychological factors are associated with changes in the health-related quality of life in inflammatory bowel disease. Inflamm Bowel Dis. 2014;20(1):92–102.
   PubMed Web of Science ®Google Scholar
• Le Berre C, Peyrin-Biroulet L, Buisson A, et al. Impact of inflammatory bowel diseases on working life: a French Nationwide Survey. Dig Liver Dis. 2019;51(7):961–966.
   PubMedGoogle Scholar
• Leenhardt R, Rivière P, Papazian P, et al. Sexual health and fertility for individuals with inflammatory bowel disease. World J Gastroenterol. 2019;25(36):5423–5433.
   PubMed Web of Science ®Google Scholar
• Haapamäki J, Turunen U, Roine RP, et al. Impact of demographic factors, medication and symptoms on disease-specific quality of life in inflammatory bowel disease. Qual Life Res. 2009;18(8):961–969.
   PubMed Web of Science ®Google Scholar
• Otto C, Barthel D, Klasen F, et al. Predictors of self-reported health-related quality of life according to the EQ-5D-Y in chronically ill children and adolescents with asthma, diabetes, and juvenile arthritis: longitudinal results. Qual Life Res. 2018;27(4):879–890.
   PubMed Web of Science ®Google Scholar
• Yellen SB, Cella DF, Webster K, et al. Measuring fatigue and other anemia-related symptoms with the functional assessment of cancer therapy (FACT) measurement system. J Pain Symptom Manage. 1997;13(2):63–74.
   PubMed Web of Science ®Google Scholar
• Reilly MC, Gerlier L, Brabant Y, et al. Validity, reliability, and responsiveness of the work productivity and activity impairment questionnaire in Crohn’s disease. Clin Ther. 2008;30(2):393–404.
   PubMed Web of Science ®Google Scholar
• Bernstein CN, Zhang L, Lix LM, et al. The validity and reliability of screening measures for depression and anxiety disorders in inflammatory bowel disease. Inflamm Bowel Dis. 2018;24(9):1867–1875.
   PubMed Web of Science ®Google Scholar
• Dibley L, Czuber-Dochan W, Woodward S, et al. Development and psychometric properties of the inflammatory bowel disease distress scale (IBD-DS): a new tool to measure disease-specific distress. Inflamm Bowel Dis. 2018;24(9):2068–2077.
   PubMed Web of Science ®Google Scholar
• Pallis AG, Vlachonikolis IG, Mouzas IA. Assessing health-related quality of life in patients with inflammatory bowel disease, in Crete, Greece. BMC Gastroenterol. 2002;2:1.
   PubMedGoogle Scholar
• van Balkom BPJ, Schoon EJ, Stockbrügger RW, et al. Effects of anti-tumour necrosis factor-alpha therapy on the quality of life in Crohn’s disease. Aliment Pharmacol Ther. 2002;16(6):1101–1107.
   PubMed Web of Science ®Google Scholar
• Casellas F, Arenas JI, Baudet JS, et al. Impairment of health-related quality of life in patients with inflammatory bowel disease: a Spanish multicenter study. Inflamm Bowel Dis. 2005;11(5):488–496.
   PubMed Web of Science ®Google Scholar
• De Almeida RS, Lisboa ACR, Moura AR. Quality of life of patients with inflammatory bowel disease using immunobiological therapy. J coloproctology. 2019;39(2):107–114.
   Google Scholar
• Irvine EJ, Feagan B, Rochon J, et al. Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Gastroenterology. 1994;106(2):287–296.
   PubMed Web of Science ®Google Scholar
• Bouguen G, Dewitte M, Siproudhis L, Peyrin-Biroulet L. Validation de la version française de l'Inflammatory Bowel Disease Questionnaire (IBDQ) chez les patients atteints d'une MICI - P.099. 2020 [cited 2021 Nov 30]. Available from: https://www.snfge.org/content/validation-de-la-version-francaise-de-l
   Google Scholar
• Ballinger G. Using generalized estimating equations for longitudinal data analysis. Organ Res Methods. 2004;7(2):127–150.
   Web of Science ®Google Scholar
• Feagan BG, Yan S, Bala M, Bao W, Lichtenstein GR. The effects of infliximab maintenance therapy on health-related quality of life. Am J Gastroenterol. 2003;98:2232–8.
   Google Scholar
• Feagan BG, Sandborn WJ, Hass S, Niecko T, White J. Health-related quality of life during natalizumab maintenance therapy for Crohn's disease. Am J Gastroenterol. 2007;102:2737–46
   Google Scholar
• Loftus EV, Feagan BG, Colombel JF, Rubin DT, Wu EQ, Yu AP, et al. Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: Patient-reported outcomes of the CHARM trial. Am J Gastroenterol. 2008;103:3132–41.
   Google Scholar
• Feagan BG, Coteur G, Tan S, Keininger DL, Schreiber S. Clinically meaningful improvement in health-related quality of life in a randomized controlled trial of certolizumab pegol maintenance therapy for Crohn's disease. Am J Gastroenterol. 2009;104:1976–83
   Google Scholar
• Targownik LE, Sexton KA, Bernstein MT, et al. The relationship among perceived stress, symptoms, and inflammation in persons with inflammatory bowel disease. Am J Gastroenterol. 2015;110(7):1001–1012.
   PubMed Web of Science ®Google Scholar
• Bernklev T, Jahnsen J, Schulz T, et al. Course of disease, drug treatment and health-related quality of life in patients with inflammatory bowel disease 5 years after initial diagnosis. Eur J Gastroenterol Hepatol. 2005;17(10):1037–1045.
   PubMed Web of Science ®Google Scholar
• Romberg-Camps MJL, Bol Y, Dagnelie PC, et al. Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in The Netherlands: the IBD-South Limburg cohort. Inflamm Bowel Dis. 2010;16(12):2137–2147.
   PubMed Web of Science ®Google Scholar
• Russel MG, Nieman FH, Bergers JM, et al. Cigarette smoking and quality of life in patients with inflammatory bowel disease. South Limburg IBD study group. Eur J Gastroenterol Hepatol. 1996;8:1075–1081.
   PubMed Web of Science ®Google Scholar
• Bernklev T, Jahnsen J, Henriksen M, et al. Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:402–412.
   PubMed Web of Science ®Google Scholar
• Stjernman H, Tysk C, Almer S, et al. Worries and concerns in a large unselected cohort of patients with Crohn’s disease. Scand J Gastroenterol. 2010;45(6):696–706.
   PubMed Web of Science ®Google Scholar
• Andersson P, Olaison G, Bendtsen P, et al. Health related quality of life in Crohn’s proctocolitis does not differ from a general population when in remission. Colorectal Dis off J Assoc Coloproctology G B Irel. 2003;5(1):56–62.
   PubMedGoogle Scholar
• Gibson PR, Weston AR, Shann A, et al. Relationship between disease severity, quality of life and health-care resource use in a cross-section of Australian patients with Crohn’s disease. J Gastroenterol Hepatol. 2007;22(8):1306–1312.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Ren W, Irvine EJ, et al. Assessing health-related quality of life in patients with inflammatory bowel disease in Zhejiang, China. J Clin Nurs. 2010;19(1–2):79–88.
   Google Scholar